科学建议——药物重新利用是否错失了一个窍门？ - Suppr

Suppr

超能文献

Scientific advice - is drug repurposing missing a trick?

作者信息

Pantziarka Pan

机构信息

Anticancer Fund, Brussels, 1853 Strombeek-Bever, Belgium.

The George Pantziarka TP53 Trust, London, UK.

出版信息

Nat Rev Clin Oncol. 2017 Aug;14(8):455-456. doi: 10.1038/nrclinonc.2017.69. Epub 2017 May 23.

DOI:10.1038/nrclinonc.2017.69

PMID:28534529

Abstract

摘要

相似文献

Scientific advice - is drug repurposing missing a trick?

Nat Rev Clin Oncol. 2017 Aug;14(8):455-456. doi: 10.1038/nrclinonc.2017.69. Epub 2017 May 23.

Repurposing Drugs in Oncology: Next Steps.

Trends Cancer. 2017 Aug;3(8):543-546. doi: 10.1016/j.trecan.2017.06.007. Epub 2017 Jul 12.

The future of off-label marketing regulations in the post-Sorrell era.

Seton Hall Law Rev. 2013;43(3):1137-63.

The Food and Drug Administration advisory committees and panels: how they are applied to the drug regulatory process.

Am J Gastroenterol. 2014 Oct;109(10):1508-12. doi: 10.1038/ajg.2014.85. Epub 2014 Jul 8.

Drug Regulation and Pricing--Can Regulators Influence Affordability?

N Engl J Med. 2016 May 12;374(19):1807-9. doi: 10.1056/NEJMp1601294.

Can you teach old drugs new tricks?

Nature. 2016 Jun 16;534(7607):314-6. doi: 10.1038/534314a.

Improving the FDA's advisory committee process.

J Clin Pharmacol. 2012 Aug;52(8):1277-83. doi: 10.1177/0091270011412962. Epub 2011 Sep 10.

Dangers of cough and cold medicines: new advisory.

Nurs Womens Health. 2008 Apr;12(2):163-5. doi: 10.1111/j.1751-486X.2008.00310.x.

[The long path (s) of placing medicines on the market].

Med Sci (Paris). 2019 Mar;35 Hors série n° 1:13-17. doi: 10.1051/medsci/2019047. Epub 2019 Apr 3.

Drug rediscovery to prevent off-label prescription reduces health care costs: the case of tioguanine in the Netherlands.

J Gastrointestin Liver Dis. 2014 Jun;23(2):123-5. doi: 10.15403/jgld.2014.1121.cjjm1.

引用本文的文献

Advances in the Repurposing and Blood-Brain Barrier Penetrance of Drugs in Pediatric Brain Tumors.

Cancers (Basel). 2025 Jan 27;17(3):439. doi: 10.3390/cancers17030439.

H1 Antihistamines-Promising Candidates for Repurposing in the Context of the Development of New Therapeutic Approaches to Cancer Treatment.

Cancers (Basel). 2024 Dec 20;16(24):4253. doi: 10.3390/cancers16244253.

The evidence for repurposing anti-epileptic drugs to target cancer.

Mol Biol Rep. 2023 Sep;50(9):7667-7680. doi: 10.1007/s11033-023-08568-1. Epub 2023 Jul 7.

Editorial: Adopting drug repurposing to overcome drug resistance in cancer.

Front Cell Dev Biol. 2023 Apr 28;11:1191682. doi: 10.3389/fcell.2023.1191682. eCollection 2023.

Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management.

J Hematol Oncol. 2022 Jul 18;15(1):97. doi: 10.1186/s13045-022-01313-4.

Epidrug Repurposing: Discovering New Faces of Old Acquaintances in Cancer Therapy.

Front Oncol. 2020 Nov 18;10:605386. doi: 10.3389/fonc.2020.605386. eCollection 2020.

Overcoming cancer therapeutic bottleneck by drug repurposing.

Signal Transduct Target Ther. 2020 Jul 2;5(1):113. doi: 10.1038/s41392-020-00213-8.

Repurposing anthelmintic agents to eradicate resistant leukemia.

Blood Cancer J. 2020 Jun 26;10(6):72. doi: 10.1038/s41408-020-0339-9.

Receptor tyrosine kinase targeting in glioblastoma: performance, limitations and future approaches.

Contemp Oncol (Pozn). 2020;24(1):55-66. doi: 10.5114/wo.2020.94726. Epub 2020 Mar 30.

Mining Drug-Target Associations in Cancer: Analysis of Gene Expression and Drug Activity Correlations.

Biomolecules. 2020 Apr 25;10(5):667. doi: 10.3390/biom10050667.

本文引用的文献

Affordable orphan drugs: a role for not-for-profit organizations.

Br J Clin Pharmacol. 2017 Jul;83(7):1595-1601. doi: 10.1111/bcp.13240. Epub 2017 Feb 8.

Effective Management of Advanced Angiosarcoma by the Synergistic Combination of Propranolol and Vinblastine-based Metronomic Chemotherapy: A Bench to Bedside Study.

EBioMedicine. 2016 Apr;6:87-95. doi: 10.1016/j.ebiom.2016.02.026. Epub 2016 Feb 17.

Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel.

Ann Oncol. 2016 Mar;27(3):379-90. doi: 10.1093/annonc/mdv617. Epub 2015 Dec 17.

Drug repurposing in oncology--patient and health systems opportunities.

Nat Rev Clin Oncol. 2015 Dec;12(12):732-42. doi: 10.1038/nrclinonc.2015.169. Epub 2015 Oct 20.

Growth Attenuation of Cutaneous Angiosarcoma With Propranolol-Mediated β-Blockade.

JAMA Dermatol. 2015 Nov;151(11):1226-9. doi: 10.1001/jamadermatol.2015.2554.

Regulatory watch: Impact of scientific advice from the European Medicines Agency.

Nat Rev Drug Discov. 2015 May;14(5):302-3. doi: 10.1038/nrd4621. Epub 2015 Apr 17.

Avoidable waste of research related to inadequate methods in clinical trials.

BMJ. 2015 Mar 24;350:h809. doi: 10.1136/bmj.h809.

The Repurposing Drugs in Oncology (ReDO) Project.

Ecancermedicalscience. 2014 Jul 10;8:442. doi: 10.3332/ecancer.2014.442. eCollection 2014.

Factors associated with success of market authorisation applications for pharmaceutical drugs submitted to the European Medicines Agency.

Eur J Clin Pharmacol. 2010 Jan;66(1):39-48. doi: 10.1007/s00228-009-0756-y. Epub 2009 Nov 20.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Scientific advice - is drug repurposing missing a trick?

Nat Rev Clin Oncol. 2017 Aug;14(8):455-456. doi: 10.1038/nrclinonc.2017.69. Epub 2017 May 23.

Repurposing Drugs in Oncology: Next Steps.

Trends Cancer. 2017 Aug;3(8):543-546. doi: 10.1016/j.trecan.2017.06.007. Epub 2017 Jul 12.

The future of off-label marketing regulations in the post-Sorrell era.

Seton Hall Law Rev. 2013;43(3):1137-63.

The Food and Drug Administration advisory committees and panels: how they are applied to the drug regulatory process.

Am J Gastroenterol. 2014 Oct;109(10):1508-12. doi: 10.1038/ajg.2014.85. Epub 2014 Jul 8.

Drug Regulation and Pricing--Can Regulators Influence Affordability?

N Engl J Med. 2016 May 12;374(19):1807-9. doi: 10.1056/NEJMp1601294.

Can you teach old drugs new tricks?

Nature. 2016 Jun 16;534(7607):314-6. doi: 10.1038/534314a.

Improving the FDA's advisory committee process.

J Clin Pharmacol. 2012 Aug;52(8):1277-83. doi: 10.1177/0091270011412962. Epub 2011 Sep 10.

Dangers of cough and cold medicines: new advisory.

Nurs Womens Health. 2008 Apr;12(2):163-5. doi: 10.1111/j.1751-486X.2008.00310.x.

[The long path (s) of placing medicines on the market].

Med Sci (Paris). 2019 Mar;35 Hors série n° 1:13-17. doi: 10.1051/medsci/2019047. Epub 2019 Apr 3.

Drug rediscovery to prevent off-label prescription reduces health care costs: the case of tioguanine in the Netherlands.

J Gastrointestin Liver Dis. 2014 Jun;23(2):123-5. doi: 10.15403/jgld.2014.1121.cjjm1.

引用本文的文献

Advances in the Repurposing and Blood-Brain Barrier Penetrance of Drugs in Pediatric Brain Tumors.

Cancers (Basel). 2025 Jan 27;17(3):439. doi: 10.3390/cancers17030439.

H1 Antihistamines-Promising Candidates for Repurposing in the Context of the Development of New Therapeutic Approaches to Cancer Treatment.

Cancers (Basel). 2024 Dec 20;16(24):4253. doi: 10.3390/cancers16244253.

The evidence for repurposing anti-epileptic drugs to target cancer.

Mol Biol Rep. 2023 Sep;50(9):7667-7680. doi: 10.1007/s11033-023-08568-1. Epub 2023 Jul 7.

Editorial: Adopting drug repurposing to overcome drug resistance in cancer.

Front Cell Dev Biol. 2023 Apr 28;11:1191682. doi: 10.3389/fcell.2023.1191682. eCollection 2023.

Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management.

J Hematol Oncol. 2022 Jul 18;15(1):97. doi: 10.1186/s13045-022-01313-4.

Epidrug Repurposing: Discovering New Faces of Old Acquaintances in Cancer Therapy.

Front Oncol. 2020 Nov 18;10:605386. doi: 10.3389/fonc.2020.605386. eCollection 2020.

Overcoming cancer therapeutic bottleneck by drug repurposing.

Signal Transduct Target Ther. 2020 Jul 2;5(1):113. doi: 10.1038/s41392-020-00213-8.

Repurposing anthelmintic agents to eradicate resistant leukemia.

Blood Cancer J. 2020 Jun 26;10(6):72. doi: 10.1038/s41408-020-0339-9.

Receptor tyrosine kinase targeting in glioblastoma: performance, limitations and future approaches.

Contemp Oncol (Pozn). 2020;24(1):55-66. doi: 10.5114/wo.2020.94726. Epub 2020 Mar 30.

Mining Drug-Target Associations in Cancer: Analysis of Gene Expression and Drug Activity Correlations.

Biomolecules. 2020 Apr 25;10(5):667. doi: 10.3390/biom10050667.

本文引用的文献

Affordable orphan drugs: a role for not-for-profit organizations.

Br J Clin Pharmacol. 2017 Jul;83(7):1595-1601. doi: 10.1111/bcp.13240. Epub 2017 Feb 8.

Effective Management of Advanced Angiosarcoma by the Synergistic Combination of Propranolol and Vinblastine-based Metronomic Chemotherapy: A Bench to Bedside Study.

EBioMedicine. 2016 Apr;6:87-95. doi: 10.1016/j.ebiom.2016.02.026. Epub 2016 Feb 17.

Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel.

Ann Oncol. 2016 Mar;27(3):379-90. doi: 10.1093/annonc/mdv617. Epub 2015 Dec 17.

Drug repurposing in oncology--patient and health systems opportunities.

Nat Rev Clin Oncol. 2015 Dec;12(12):732-42. doi: 10.1038/nrclinonc.2015.169. Epub 2015 Oct 20.

Growth Attenuation of Cutaneous Angiosarcoma With Propranolol-Mediated β-Blockade.

JAMA Dermatol. 2015 Nov;151(11):1226-9. doi: 10.1001/jamadermatol.2015.2554.

Regulatory watch: Impact of scientific advice from the European Medicines Agency.

Nat Rev Drug Discov. 2015 May;14(5):302-3. doi: 10.1038/nrd4621. Epub 2015 Apr 17.

Avoidable waste of research related to inadequate methods in clinical trials.

BMJ. 2015 Mar 24;350:h809. doi: 10.1136/bmj.h809.

The Repurposing Drugs in Oncology (ReDO) Project.

Ecancermedicalscience. 2014 Jul 10;8:442. doi: 10.3332/ecancer.2014.442. eCollection 2014.

Factors associated with success of market authorisation applications for pharmaceutical drugs submitted to the European Medicines Agency.

Eur J Clin Pharmacol. 2010 Jan;66(1):39-48. doi: 10.1007/s00228-009-0756-y. Epub 2009 Nov 20.